After two years of stealth R&D, Kokuma is stepping into the spotlight. The European beauty biotech startup will officially reveal the clinical results of its first two patented actives at the 35th IFSCC Congress, held 15–18 September 2025 in Cannes. Hosted by the Société Française de Cosmétologie, the 35th IFSCC Congress brings together the global leaders in cosmetic R&D under the theme: “The Future is Science.”
Kokuma will present via a poster and presentation to the IFSCC scientific jury, this moment marks Kokuma’s entry into the global cosmetic science arena.
🌿 TONASULIKE-D
An AI-discovered, natural depigmenting active.
🔬 -86% melanin production | New biological pathway | Visible spot reduction from 21 days. Safe, effective, and clinically validated across all skin tones.
⚙️ TONASULIKE-P
The world’s first UV-free melanin booster.
☀️ Doubles melanin synthesis without sun exposure | Natural glow in just 10 days
Patented, green chemistry-derived — a true breakthrough in luminous skin without UV risk.
“This moment is the culmination of two years of rigorous biotech and AI-powered research. We set out to solve a skincare challenges: rebalancing skin tone safely and naturally — and we’re proud to share the science behind it at IFSCC,”
says Yannick Quesnel, Co-founder and Chief Scientific Officer at Kokuma.
Kokuma will be on-site in Cannes with a dedicated stand, hosting 1:1 meetings and an exclusive media breakfast.
